NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 45802-0141-67 — Ciclopirox 8% topical solution, 6.6 mL bottleAI (115 hospitals, 30,301–31,255 samples)
• NDC 51991-0898-99 — Rivastigmine 9.5 mg/24 hour skin patchAI (103 hospitals, 30,301–31,255 samples)
• NDC 60687-0714-44 — Chlorhexidine gluconate 0.12% mouth rinseAI (156 hospitals, 30,301–31,255 samples)
• NDC 62559-0420-11 — Mesalamine 4 g/60 mL enemaAI (118 hospitals, 30,301–31,255 samples)
• NDC 63323-0426-15 — Rocuronium injection, 10 mg per mLAI (89 hospitals, 30,301–31,255 samples)
• NDC 65219-0140-04 — Norepinephrine 1 mg/mL intravenous solutionAI (72 hospitals, 30,301–31,255 samples)
• NDC 66689-0106-01 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (133 hospitals, 30,301–31,255 samples)
• NDC 66689-0106-50 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (68 hospitals, 30,301–31,255 samples)
• NDC 68462-0297-35 — CICLOPIROX 0.77 % TOPICAL CREAMAI (70 hospitals, 30,301–31,255 samples)
• NDC 47335-0631-49 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (160 hospitals, 30,301–31,255 samples)
• NDC 00378-9072-16 — Rivastigmine 13.3 mg/24-hour skin patchAI (92 hospitals, 30,301–31,255 samples)
• NDC 00487-9601-30 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (133 hospitals, 30,301–31,255 samples)
• NDC 68462-0297-17 — CICLOPIROX 0.77 % TOPICAL CREAMAI (129 hospitals, 30,301–31,255 samples)
• NDC 70756-0608-12 — Formoterol inhalation solution for nebulizerAI (57 hospitals, 30,301–31,255 samples)
• NDC 71288-0718-10 — Rocuronium injection for muscle relaxation during surgeryAI (101 hospitals, 30,301–31,255 samples)
• NDC 00409-7969-11 — Cardioplegic solution containing potassium for heart surgeryAI (61 hospitals, 30,301–31,255 samples)
• NDC 51672-1272-02 — Nystatin-triamcinolone topical ointmentAI (107 hospitals, 30,301–31,255 samples)
• NDC 70860-0651-10 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (70 hospitals, 30,301–31,255 samples)
• NDC 16714-0985-01 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL CREAMAI (125 hospitals, 30,301–31,255 samples)
• NDC 67877-0251-30 — Triamcinolone 0.1% topical creamAI (132 hospitals, 30,301–31,255 samples)
• NDC 16714-0985-02 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL CREAMAI (66 hospitals, 30,301–31,255 samples)
• NDC 70069-0421-03 — Latanoprost 0.005% eye dropsAI (148 hospitals, 30,301–31,255 samples)
• NDC 00536-1307-23 — OLOPATADINE 0.2 % EYE DROPSAI (56 hospitals, 30,301–31,255 samples)
• NDC 63739-0052-57 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (118 hospitals, 30,301–31,255 samples)
• NDC 16714-0018-30 — Budesonide inhalation suspension for nebulizerAI (87 hospitals, 30,301–31,255 samples)
• NDC 70121-1586-03 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (54 hospitals, 30,301–31,255 samples)
• NDC 00378-9691-62 — Levalbuterol 0.63 mg/3 mL nebulizer solutionAI (57 hospitals, 30,301–31,255 samples)
• NDC 00378-9692-52 — Levalbuterol 1.25 mg/3 mL nebulizer solutionAI (67 hospitals, 30,301–31,255 samples)
• NDC 76204-0018-11 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (46 hospitals, 30,301–31,255 samples)
• NDC 16714-0986-02 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAMAI (54 hospitals, 30,301–31,255 samples)
• NDC 70700-0106-16 — CLOBETASOL 0.05 % TOPICAL OINTMENTAI (78 hospitals, 30,301–31,255 samples)
• NDC 70748-0261-01 — Formoterol inhalation solution for nebulizerAI (79 hospitals, 30,301–31,255 samples)
• NDC 00378-9691-52 — Levalbuterol 0.63 mg/3 mL nebulizer solutionAI (107 hospitals, 30,301–31,255 samples)
• NDC 00378-9692-62 — Levalbuterol 1.25 mg/3 mL nebulizer solutionAI (39 hospitals, 30,301–31,255 samples)
• NDC 45802-0496-14 — DESOXIMETASONE 0.25 % TOPICAL OINTMENTAI (62 hospitals, 30,301–31,255 samples)
• NDC 60687-0616-44 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (66 hospitals, 30,301–31,255 samples)
• NDC 62756-0277-03 — Arformoterol nebulizer solution (15 mcg per 2 mL)AI (48 hospitals, 30,301–31,255 samples)
• NDC 16714-0267-01 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENTAI (71 hospitals, 30,301–31,255 samples)
• NDC 51407-0499-05 — OLOPATADINE 0.1 % EYE DROPSAI (40 hospitals, 30,301–31,255 samples)
• NDC 66993-0022-35 — Levalbuterol 0.63 mg nebulizer solutionAI (120 hospitals, 30,301–31,255 samples)
• NDC 70121-1586-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (53 hospitals, 30,301–31,255 samples)
• NDC 16714-0267-02 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENTAI (56 hospitals, 30,301–31,255 samples)
• NDC 00591-3524-26 — Testosterone 1% transdermal gelAI (39 hospitals, 30,301–31,255 samples)
• NDC 70748-0261-60 — Formoterol fumarate 20 mcg nebulizer solutionAI (97 hospitals, 30,301–31,255 samples)
• NDC 00713-0661-15 — DESONIDE 0.05 % TOPICAL CREAMAI (37 hospitals, 30,301–31,255 samples)
• NDC 43598-0894-11 — Nitroglycerin 24-hour skin patchAI (32 hospitals, 30,301–31,255 samples)
• NDC 70860-0651-41 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (47 hospitals, 30,301–31,255 samples)
• NDC 54766-0799-64 — Hydrocortisone and pramoxine cream, 4 g tubeAI (66 hospitals, 30,301–31,255 samples)
• NDC 00395-0605-94 — Citric acid powder (bulk granules)AI (26 hospitals, 30,301–31,255 samples)
• NDC 00527-5120-70 — Lactulose oral solutionAI (33 hospitals, 30,301–31,255 samples)